PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.\', \'Section of Vascular Thrombosis and Inflammation, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, USA.\', \'Division of Rheumatology, Department of Internal Medicine and.\', \'Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1172/jci.insight.140971140971
?:hasPublicationType
?:journal
  • JCI insight
is ?:pmid of
?:pmid
?:pmid
  • 32530438
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • New (re)purpose for an old drug: purinergic modulation may extinguish the COVID-19 thromboinflammatory firestorm.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all